Cosmos Health COSM 深 沪
已收盘 11-06 16:00:00 美东时间
0.3049
+0.015
+5.17%
华盛通- 最 高0.3076
- 今 开0.2901
- 成交量 105.86万股
- 最 低 0.29
- 昨 收 0.2899
- 总市值 3068.32万
- 52周最高 0.7696
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 0.1616
- 委 比 -97.74%
- 总股本 1.01亿
- 历史最高 98.00
- 量 比 0.55
- 振 幅 6.07%
- 历史最低 0.1616
- 每 手 1
- 风险率 0.13%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cosmos Health U.S. Active Subscriptions Up 92% And Monthly Subscription Value Rises 94% In Two Weeks
Active subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14, 2026 Monthly subscription value up 94%: $1,787,585 at standard renewal pricing as of October 28, 2026, up from $919,945 on October 14, 2026 Order volume up 90%: 20,677 online checkout o...
10-29 21:27
Cosmos Health Announces Expansion Of Its E-Commerce, Subscription Operations To Australia, New Zealand, Oceania Region
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the expansion of its e-commerce and subscription business to Australia, New Zealand and the broader Oceania region. The business is now live across the r...
10-23 03:56
Cosmos Health Record One-Day U.S. Direct-To-Consumer Sales Of $92K+ On October 11 And $902K In 30 Days
United States direct-to-consumer sales reached a record of more than $92,000 in a single day on October 11, 2026. Sales over the past 30 days totaled $902,000, while average daily sales over the past 10 days exceeded $60,000, double the 30-day average. The figures cover sales through the Company's ...
10-13 21:33
Cosmos Health Sees Q3 Sales $17.400M vs $20.886M Est
Cosmos Health (NASDAQ:COSM) sees Q3 sales of $17.400 million vs $20.886 million analyst estimate.
10-07 21:40
Cosmos Health FY2026 Revenue expected to be more than $90.000M vs $84.300M Est
Cosmos Health (NASDAQ:COSM) FY2026 Revenue expected to be more than $90.000M vs $84.300M Est
10-07 21:40
Cosmos Health's Cana Laboratories Subsidiary Achieves Over $20M In Revenue
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that the contract manufacturing ("CMO") pipeline of its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has surpassed $20 million in implied re...
09-28 20:04
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
Cosmos Health Inc. has retired its $8 million senior secured convertible note a year ahead of its August 2027 maturity, simplifying its capital structure and eliminating further dilution. The company has also reduced its operating cash requirements by over 30%, strengthened its liquidity position with diversified assets, including Bitcoin holdings in a gain position, and initiated a $5 million share repurchase program following record revenue gro...
08-28 13:30
Cosmos Health shares are trading higher after the company announced an exclusive distribution agreement with Innova Healthcare for 126K units of its proprietary Sky Premium Life range of food supplements.
Cosmos Health shares are trading higher after the company announced an exclusive distribution agreement with Innova Healthcare for 126K units of its proprietary Sky Premium Life range of food supplements.
08-21 01:10
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
Cosmos Health Inc. has signed an exclusive distribution agreement with Innova Healthcare in Saudi Arabia for its Sky Premium Life food supplements. The deal includes an initial purchase order of 126,000 units and exclusive rights for five years, with potential renewal. Innova, backed by major investors like Alkhabeer Capital, operates over 250 pharmacies and expects to handle more than 5 million units over the initial term. The Saudi nutraceutica...
08-20 13:30
Cosmos Health Q2 EPS $(0.10) Misses $0.01 Estimate, Sales $18.986M Miss $19.420M Estimate
Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.01 by 1100 percent. This is unchanged from the same period last year. The company reported quarterly sales of $18.986 million which missed the analyst consensus estimate of $1...
08-19 21:05
